Bayer Intellectual Property Gmbh

Bayer Pharma Aktiengesellschaft

Bayer Oy

Schering Aktiengesellschaft

Bernhard Lindenthal

Ulrike Fuhrmann

Bernd Buchmann

Heikki Lyytikäinen

Anne Mengel

Andrea Rotgeri

Harri Jukarainen

Peter Serno

Nico Bräuer

Antonius Ter Laak

Ulrike Röhn

Rolf Schürmann

Jyrki Pihlaja

Ina Gröticke

Sascha General

Manja Ahola

Bernd Duesterberg

Satu Kleemola

Tero Parkatti

Tuula Valo

Werner Skuballa

William J Guilford

Daryl Faulds

Luisella Toschi

Gernot Langer

Katrin Waellnitz

Stefanie Lindemann

Judy Li

The invention relates to a method for contraception and for reducing menstrual problems and inducing amenorrhea, wherein an intrauterine delivery device is used for the controlled release of a combination of progestogen or a drug having a progestogenic activity and at least one therapeutically active substance capable of preventing or suppressing abnormal and/or irregular endometrial bleeding over a prolonged period of time.

Intrauterine delivery system for contraception

The invention relates to pharmaceutical compositions for emergency contraception, to the use of levonorgestrel in combination with COX inhibitors for the preparation of pharmaceutical compositions for the stated purpose, and to a method for preparing these pharmaceutical compositions.

Pharmaceutical composition for emergency contraception

The invention relates to a pharmaceutical composition for non-hormonal, on-demand contraception and to processes for preparing this pharmaceutical composition. The latter comprises 2H-indazole as novel EP2 receptor antagonists in combination with COX inhibitors. The invention furthermore provides a method for non-hormonal female-controlled on-demand contraception where a pharmaceutical composition comprising EP2 receptor antagonists in combination with COX inhibitors is taken on demand prior to expected sexual intercourse.

Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception

The invention relates to a method of hormonal female controlled 'on demand' contraception, in which a pharmaceutical preparation comprising a COX inhibitor and levonorgestrel is taken on demand prior to expected sexual intercourse. Further subjects of the invention relate to pharmaceutical compositions and application regimes for 'on demand' contraception.

Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception

The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP-receptor. 

[object Object]

The present invention relates to 9-chloroprostaglandin derivatives of the general formula I which may be advantageous for the treatment of fertility problems. 

9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Growing community of inventors

Berlin, Germany

Bernhard Lindenthal